NSCLC Targeted Therapies Update: Should We Consider EGFR Targeted Therapy in Adjuvant Setting?
By
Nebraska Oncology Society
FEATURING
Gregory Riely
By
Nebraska Oncology Society
FEATURING
Gregory Riely
Login to view comments.
Click here to Login